Péter Holló

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

Thomas Ruzicka, Charles Lynde, Gregor B. E. Jemec et al. · British Journal of Dermatology · 2008 · 399 citations

Severe Che Refractory, Ophthalmology, Atopic Dermatitis +10

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

Andrea Vaclavkova, Sergio Chimenti, Petr Arenberger et al. · The Lancet · 2014 · 144 citations

Placebo-controlled Phase 2, Medicine, Clinical Trials +5

Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary

Emese Herédi, Fanni Rencz, Orsolya Balogh et al. · The European Journal of Health Economics · 2014 · 96 citations · Full text

Autoimmune Disease, Atopic Dermatitis, Medicine +6

Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study

Hajnalka Jókai, József Szakonyi, Orsolya Kontár et al. · Journal of the American Academy of Dermatology · 2013 · 87 citations

Inflammation, Medicine, Immunology +8

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients

Adrienn Katalin Poór, Fanni Rencz, Valentin Brodszky et al. · Quality of Life Research · 2017 · 74 citations

Measurement Properties, Psoriasis Patients, Autoimmune Disease +7